Navigation Links
Molecular Devices Relaunches with HiveMind Marketing
Date:6/14/2010

HiveMind Marketing, Inc. (www.hivemindinc.com), a new marketing “mashup” that integrates web design and development, as well as email, search, and social media marketing, announced today that the firm has been selected as agency of record for Molecular Devices—formerly MDS Analytical Technologies— a leader in high-performance BioAnalytical instruments, software, and assays for basic biology and drug discovery research as well as biologics and bioassay development. Molecular Devices will retain HiveMind Marketing's services to rebrand the company, redesign and develop a new website, manage email campaigns, and increase lead generation and website traffic.

San Jose, CA (PRWEB) June 14, 2010 -- HiveMind Marketing, Inc. (hivemindinc.com), a new marketing “mashup” that integrates web design and development, as well as email, search, and social media marketing, announced today that the firm has been selected as agency of record for Molecular Devices—formerly MDS Analytical Technologies— a leader in high-performance BioAnalytical instruments, software, and assays for basic biology and drug discovery research as well as biologics and bioassay development. Molecular Devices will retain HiveMind Marketing's services to rebrand the company, redesign and develop a new website, manage email campaigns, and increase lead generation and website traffic.

"We brought HiveMind Marketing onboard to significantly increase our web visibility to our key target audiences in industry and research: medicinal chemists, screening bioloists, biochemists and chemical biologists ," said Lisa English, Director of Marketing Communications for Molecular Devices. "HiveMind Marketing’s strong experience with SEO and PPC gives us confidence that we can drive traffic and additional revenues as we expand and acquire new clients worldwide, and HiveMind’s overall experience in digital lead generation will help increase efficiency in all our online marketing campaigns."

HiveMind Marketing’s involvement with Molecular Devices began in Q1 with new branding for the company to reintroduce Molecular Devices to key target audiences. Since that time, the company has developed new email and collateral templates, new print advertising for scientific journals, designed a new content-management-based website, which will launch in Q3, and moved the company over to LyrisHQ to take advantage of integrated email marketing.

"We're very happy about beginning this partnership with Molecular Devices," said Tom Lauck, president and CEO of HiveMind. "It’s exciting to work with them, promoting their renewed commitment to the market and new dedication to marketing effectiveness. Our partnership has already produced remarkable results and we hope to continue that trend with the launch of their new website, as well as email marketing, search optimization, search marketing, marketing automation and eventually social media marketing campaigns."


About Molecular Devices

Molecular Devices (moldev.com/home.html) offers a spectrum of detection technologies and support all throughput needs—from dedicated single readout instruments to integrated multi-instrument systems and everything in between. With a unique combination of biological knowledge, applications and technical expertise, and patented core technologies; a history of first-to-market products, a complete understanding of workflows in regulated and non-regulated labs, and a sincere dedication to customers; we are the provider of choice for cost-effective, performance-driven BioAnalytical Systems that detect and decode biology to support your discovery objectives. The company is headquartered in Silicon Valley with offices in Bavaria, Beijing, London, Philadelphia, Shanghai, Taipei, and Tokyo to serve its global user base as well as the international Bioresearch, Biopharma, and Biotesting communities.

About HiveMind Marketing, Inc.

Founded by Tom Lauck, a long-time Silicon Valley marketing practitioner, HiveMind Marketing, Inc. is a new marketing “mashup” that integrates web design and development, as well as email, search, and social marketing.

HiveMind Marketing understands that marketing today requires engaging audiences that are connected in new ways. They read blogs. They use RSS feeds to stay in contact with minimal effort. They join social networks to affirm their bonds. They pass along information about themselves and about others. They share who they are and what they are about.

As marketers, we're just to beginning to realize that engaging this HiveMind requires a dramatically different skill set. You can't blast them with ads, spam them with emails, fill their mailboxes with junkmail, or interrupt their TV programs with commercials. It simply doesn't work. You have to engage them.
HiveMind Marketing strengthens a company’s overall sales and marketing effort through a broad range of tactics, including:

 
  • aligning sales and marketing
  • improving the company website
  • fine-tuning landing pages
  • enhancing search engine results
  • automating lead nurturing processes
  • building online communities
  • strengthening outbound marketing activities
  • measuring the results

With offices in San Jose, California, the heart of Silicon Valley, HiveMind Marketing is redefining the way progressive organizations engage prospects and customers. For more information on HiveMind Marketing, please visit HiveMindinc.com.

# # #

Read the full story at http://www.prweb.com/releases/2010/06/prweb4130724.htm.


'/>"/>
Source: PRWeb
Copyright©2010 Vocus, Inc.
All rights reserved  

Related medicine news :

1. Molecular imaging detects recurrent prostate cancer
2. Molecular Signatures in Post-Mortem Brain Tissue of Younger Individuals at High Risk for Alzheimer's Disease
3. Molecular imaging and CT colonography team up to bring comfort to patients
4. Acupunctures molecular effects pinned down
5. Salt Lake City proclaims Molecular Imaging Days during SNMs Annual Meeting in June
6. Scientists discover the molecular heart of collective behavior
7. News from Molecular Medicine
8. Molecular marker could help spot pancreatic cancer early
9. Molecular discovery points to new therapies for brain tumors
10. USC researchers discover new molecular subtype of brain cancer
11. The Association for Molecular Pathology celebrates ruling in DNA patent case
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Molecular Devices Relaunches with HiveMind Marketing 
(Date:4/28/2017)... Edinburg, Texas (PRWEB) , ... April 28, 2017 , ... ... a plaque in recently to the labor and delivery team at Women’s Hospital at ... generous mothers who give birth at the hospital and decide to donate. , ...
(Date:4/28/2017)... ... April 28, 2017 , ... Yisrayl Hawkins, Pastor and Overseer at The House of Yahweh ... Creator responds to and which He does not. Yisrayl says with so many titles ... the true name, but he says with a little Scripture, backed with a lot of ...
(Date:4/28/2017)... ... 28, 2017 , ... NuevaCare, a leading home care agency based in San ... Alto, is proud to announce information upgrades to its blog in the form of ... on topics such as home care (generally) as well as senior care and home ...
(Date:4/27/2017)... ... 2017 , ... The Incentive Research Foundation is pleased to ... a groundbreaking analysis of how behavioral economics can be applied to the incentive, ... programs, the report highlights proven behavioral economics approaches and the powerful role emotions ...
(Date:4/27/2017)... ... April 27, 2017 , ... SyncDog, Inc. ... at MobileIron Live! 2017 in Santa Clara, California. Each year, MobileIron ... approach to helping organizations maximize the benefits of mobility in their operations securely. ...
Breaking Medicine News(10 mins):
(Date:4/19/2017)... NASHVILLE , Tenn. and DALLAS , ... and EndoStim, Inc., announced that the first patients in ... with the EndoStim device in the Lower Esophageal Sphincter ... is a minimally-invasive implantable device designed to provide long-term ... through neurostimulation. GERD affects nearly 65 million ...
(Date:4/19/2017)... , April 19, 2017  Novartis today announced ... National Heart, Lung, and Blood Institute (NHLBI) of ... 58% of patients with treatment-naïve severe aplastic anemia ... treated with eltrombopag at the initiation of and ... study evaluated three sequential treatment groups, or cohorts. ...
(Date:4/18/2017)... April 18, 2017 Research and Markets has ... report to their offering. ... The global arthroscopy devices market to grow at a CAGR of ... Arthroscopy Devices Market 2017-2021, has been prepared based on an in-depth ... market landscape and its growth prospects over the coming years. The ...
Breaking Medicine Technology: